Should we screen for type 2 diabetes? Evaluation against national screening committee criteria

British Medical Journal

Volumn 322, Issue 7292, 2001, Pages 986-988

  Wareham, N J ^a   Griffin, S J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE POLICY; HUMAN; MEDICAL EDUCATION; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCREENING TEST;

EID: 0035926055     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.322.7292.986     Document Type: Review

References (27)

1. Undiagnosed NIDDM: Clinical and public health issues
2. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis
3. UK prospective diabetes study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors
4. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM)
5. Glucose intolerance in the community; the Isle of Ely diabetes project
6. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
7. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study
8. Cost-effectiveness of the primary prevention of non-insulin dependent diabetes mellitus
9. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
10. Evidence for bimodality of two hour plasma glucose concentrations in Mexican Americans: Results from the San Antonio heart study
11. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes
12. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years
13. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
14. Dysglycaemia and risk of cardiovascular disease
15. Screening for NIDDM in nonpregnant adults: A review of principles, screening tests, and recommendations
16. Performance of an NIDDM screening questionnaire based on symptoms and risk factors
17. Diabetes risk score: Towards earlier detection of type 2 diabetes in general practice
18. The cost-effectiveness of screening for type 2 diabetes
19. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
20. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
21. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian simvastatin survival study (4S)
22. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
23. Psychological impact of predicting individuals' risks of illness: A systematic review
24. Screening for type 2 diabetes mellitus: A decision analytic approach